Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Zydus gets USFDA final approval to market drugs for stomach ailments

      Zydus gets USFDA final approval to market drugs for stomach ailments

      Ruby Khatun Khatun19 March 2018 11:00 AM IST
      New Delhi: Zydus Cadila said it has got the final nod from US Food and Drug Administration (USFDA) for marketing Omeprazole and Sodium bicarbonate...
      Anti dumping duty imposed on Ofloxacin import from China

      Anti dumping duty imposed on Ofloxacin import from China

      Ruby Khatun Khatun19 March 2018 10:15 AM IST
      New Delhi: India has imposed anti dumping duty on import of Chinese pharma product, used in the treatment of certain infections, to protect domestic...
      Parliamentary panel slams govt over delay in framing law to regulate Ayush ads

      Parliamentary panel slams govt over delay in framing law to regulate Ayush ads

      Ruby Khatun Khatun19 March 2018 10:00 AM IST
      New Delhi: A parliamentary committee has rapped the health and AYUSH ministries for their "laid back" approach in the framing of a new legislation to...
      Novartis India Vice Chairman and Managing Director Jawed Zia resigns

      Novartis India Vice Chairman and Managing Director Jawed Zia resigns

      Ruby Khatun Khatun19 March 2018 9:30 AM IST
      New Delhi: Novartis India said its Vice Chairman and Managing Director Jawed Zia has decided to step down from the post."Jawed Zia, Vice Chairman...
      ChrysCapital makes Surprise bid for Mankind Pharma stake

      ChrysCapital makes Surprise bid for Mankind Pharma stake

      Ruby Khatun Khatun19 March 2018 9:27 AM IST
      Mumbai: As the Mankind, Pharma deal is entering in the last stage, it is expected to heat up and create a high competition between the firms. The...
      Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways

      Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways

      Ruby Khatun Khatun18 March 2018 3:51 PM IST
      New Delhi: To provide their Multidrug-Resistant (MDR) TB drugs at cheaper rates to TB patients in India so that patients could easily access to them...
      Dr Reddys launches allergy relief tablets in US

      Dr Reddy's launches allergy relief tablets in US

      Ruby Khatun Khatun18 March 2018 11:00 AM IST
      New Delhi: Drug firm Dr Reddy's Laboratories has launched levocetirizine dihydrochloride tablets, used for relieving allergies, in the US market.In a...
      CDSCO raids 2 firms in Uttarakhand for making drugs without approval

      CDSCO raids 2 firms in Uttarakhand for making drugs without approval

      Ruby Khatun Khatun18 March 2018 10:30 AM IST
      New Delhi: The Central Drug Standards Control Organisation (CDSCO) has conducted raids at two firms based in Haridwar and Roorkee and is mulling...
      CDSCO to create forum to discuss various issue pertaining to drug regulations

      CDSCO to create forum to discuss various issue pertaining to drug regulations

      Ruby Khatun Khatun18 March 2018 10:00 AM IST
      New Delhi: Through an office order dated 14th March 2018, the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health...
      Lundbeck to buy Parkinsons drug developer in potential 1.1 billion dollars deal

      Lundbeck to buy Parkinson's drug developer in potential 1.1 billion dollars deal

      Ruby Khatun Khatun18 March 2018 9:45 AM IST
      COPENHAGEN: Lundbeck agreed to buy Prexton Therapeutics, a specialist in treatments for brain disorders, in a deal potentially worth $1.1 billion, the...
      Merck can be sued over generic drug injury: Massachusetts court

      Merck can be sued over generic drug injury: Massachusetts court

      Ruby Khatun Khatun18 March 2018 9:30 AM IST
      BOSTON: Massachusetts’ top court opened the door for consumers to sue Merck & Co Inc and other makers of brand-name drugs over injuries blamed not...
      Selling Unapproved FDC drugs: Wockhardt, two others under CDSCO scanner

      Selling Unapproved FDC drugs: Wockhardt, two others under CDSCO scanner

      Ruby Khatun Khatun17 March 2018 5:15 PM IST
      New Delhi: The Central Drug Standards Control Organization (CDSCO) has put several pharma firms under its scanner for allegedly manufacturing and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok